Stevens Capital Management’s AstraZeneca AZN Stock Holding History

Stevens Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,599	Closed	-$360K	–	131
2020 Q4	$360K	Buy	3,599 +785	+28%	+$83.1K	0.18%	89
2020 Q3	$308K	Buy	+2,814	New	+$313K	0.11%	94
2018 Q4	–	Sell	-3,930	Closed	-$311K	–	697
2018 Q3	$311K	Buy	+3,930	New	+$297K	0.01%	587
2017 Q1	–	Sell	-9,136	Closed	-$499K	–	863
2016 Q4	$499K	Buy	+9,136	New	+$519K	0.02%	574
2016 Q3	–	Sell	-12,609	Closed	-$761K	–	903
2016 Q2	$761K	Sell	12,609 -2,329	-16%	-$135K	0.03%	473
2016 Q1	$841K	Sell	14,938 -12,057	-45%	-$724K	0.03%	464
2015 Q4	$1.83M	Buy	+26,995	New	+$1.77M	0.07%	301
2015 Q3	–	Sell	-32,902	Closed	-$2.1M	–	975
2015 Q2	$2.1M	Buy	32,902 +27,541	+514%	+$1.89M	0.08%	274
2015 Q1	$367K	Sell	5,361 -8,151	-60%	-$566K	0.01%	676
2014 Q4	$951K	Buy	13,512 +10,481	+346%	+$750K	0.03%	430
2014 Q3	$217K	Buy	+3,031	New	+$222K	0.01%	833
2014 Q2	–	Sell	-18,573	Closed	-$1.21M	–	1055
2014 Q1	$1.21M	Sell	18,573 -3,333	-15%	-$215K	0.03%	443
2013 Q4	$1.3M	Buy	+21,906	New	+$1.19M	0.04%	416
2013 Q3	–	Sell	-99,390	Closed	-$4.7M	–	1016
2013 Q2	$4.7M	Buy	+99,390	New	+$5.06M	0.16%	176

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stevens Capital Management's AZN Position: Q1 2021 in Review

Stevens Capital Management sold out of AstraZeneca (AZN) in Q1 2021, closing a stake of 3,599 shares — an estimated $360K sold.

Stevens Capital Management first reported a position in AZN in Q2 2013 and held it in 14 quarters. The position peaked at $4.7M in Q2 2013. 756 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

Stevens Capital Management reported no remaining AstraZeneca position as of Q1 2021 after selling out during the quarter.
Stevens Capital Management sold 3,599 AstraZeneca shares in Q1 2021, an estimated $360K.
Stevens Capital Management first reported a position in AstraZeneca in Q2 2013 and held it in 14 quarters.
Stevens Capital Management's AstraZeneca position peaked at $4.7M in Q2 2013.
756 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Stevens Capital Management's 13F filing for Q1 2021, filed 11 May 2021.